Brainstorm Cell (BCLI): Rasio utang jangka cendhak marang ekuitas
Brainstorm Cell (BCLI) is actively developing protocols for NurOwn therapy aimed at combating ALS, currently undergoing the regulatory approval stage. The business relies on synergy with specialized research centers to restore brain functions. Meanwhile, the R&D model is based on outsourced testing, and the indicator stands at 0.00. The financial price chart below demonstrates the dynamics of the company's debt and equity.
Rincian analitis perusahaan brainstorm-cell.com (BCLI)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Total Utang marang Modal Brainstorm Cell|BCLI - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas BrainStorm Cell Therapeutics|BCLI - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Brainstorm Cell Therapeutics, Inc.|BCLI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BrainStorm Cell Therapeutics
Analisis komprehensif perusahaan:Brainstorm Cell Therapeutics, Inc.
The stability of Brainstorm Cell (BCLI) depends on the seamless operation of costly cryogenic logistics, which requires high liquidity to minimize supply chain disruption risks. This metric compares the volume of short-term borrowings against equity, determining the business's degree of dependence on external refinancing and its level of financial autonomy. By analyzing changes in the ratio of current liabilities to equity, an investor assesses the company's resilience to creditor pressure and the risk of bankruptcy.
Analisis perusahaan pesaing
Biogen Corp - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Neurocrine Corp NBIX|Rasio utang jangka cendhak marang ekuitas RGC (Regencell Bioscience)|axsome.com - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas ACADIA Pharmaceuticals Inc. (ACAD)|XENE: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas VKTX|Supernus Corp (SUPN) - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal Catalyst Pharmaceuticals|Utang jangka cendhak marang ekuitas DNLI|Harmony Biosciences Holdings, Inc. (HRMY) - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Biohaven Ltd (BHVN)|Utang jangka cendhak marang modal AMLX (Amylyx)|Utang jangka cendhak marang modal Trevi Corp TRVI|Utang jangka cendhak marang modal PRAX (Praxis Precision Medicines)|AVXL: Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas CeriBell|PRTA (Prothena Biosciences) - Rasio utang jangka cendhak marang modal|ALEC: Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Annexon Biosciences Inc. (ANNX)|Rasio utang jangka cendhak marang ekuitas Omeros Corporation|Rasio silihan jangka cendhak marang modal NGNE (neurogene.com)|ACIU: Utang jangka cendhak marang ekuitas|Voyager Therapeutics Inc - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Neumora Therapeutics Inc (NMRA)|SCLX: Rasio tanggungan utang jangka cendhak marang modal|TVGN (Tevogen Bio Holdings) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Alpha Cognition Inc.|CGTX - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Inhibikase Therapeutics Inc|Utang jangka cendhak marang modal SAVA (Cassava)|Rasio utang jangka cendhak marang ekuitas assertiotx.com (ASRT)|COYA: Utang jangka cendhak marang modal|VistaGen Therapeutics, Inc. - Kewajiban jangka cendhak marang modal|OVID - Utang jangka cendhak marang ekuitas|ABOS: Utang jangka cendhak marang ekuitas|CervoMed Inc (CRVO) - Utang jangka cendhak marang ekuitas|Alterity Therapeutics Limited (ATHE) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal Clene Inc|Utang jangka cendhak marang ekuitas PepGen Corp|Utang jangka cendhak marang modal JUNS (Jupiter Neurosciences)|Rasio utang jangka cendhak marang ekuitas RLMD (Relmada Therapeutics Inc)|Utang jangka cendhak marang ekuitas Annovis Bio Corp ANVS|Utang jangka cendhak marang ekuitas Grace Therapeutics Inc GRCE|Utang jangka cendhak marang modal AIFF (Firefly Neuroscience, Inc)|KLTO: Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas neurosense-tx.com|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal MTVA (MetaVia Inc.)|Kewajiban jangka cendhak marang modal NeurAxis Inc (NRXS)|Rasio utang jangka cendhak marang ekuitas HSDT|Utang jangka cendhak marang modal PASG (passagebio.com)|Utang jangka cendhak marang ekuitas Neuphoria Therapeutics|Minerva Neurosciences Inc - Rasio tanggungan utang jangka cendhak marang modal|ATHA (Athira) - Utang jangka cendhak marang ekuitas|ADXN - Kewajiban jangka cendhak marang modal|alzamend.com (ALZN) - Utang jangka cendhak marang modal|CYCN (Cyclerion Therapeutics, Inc.) - Utang jangka cendhak marang ekuitas|PTIX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Pasithea|Utang jangka cendhak marang modal CRGT|Utang jangka cendhak marang modal Avenue Therapeutics Inc (ATXI)|Utang jangka cendhak marang modal CARA|chromocell.com - Koefisien utang jangka cendhak marang modal|Eliem (ELYM) - Utang jangka cendhak marang ekuitas|ITCI: Rasio utang jangka cendhak marang modal|Longboard Pharma - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Marinus Pharma|NKGen Biotech, Inc. (NKGN) - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal NRBO|Sage Therapeutics - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal SNPX (Synaptogenix Inc.)|Utang jangka cendhak marang ekuitas Trevena, Inc|Vigil Neuroscience Inc. - Rasio tanggungan utang jangka cendhak marang modal|WENA: Utang jangka cendhak marang ekuitas|cerevel.com (CERE) - Rasio utang jangka cendhak marang ekuitas